🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@ErinWilfongMD of @VUMCRheum discusses the challenges of diagnosing CTD-ILD and the harms of an IPF misdiagnosis and delayed treatment. @VUMCLung spr.ly/6015HBWfN

New Lupus S&M: a commentary by Duke Forge Co-Director & rheumatologist Megan Clowse (@DrBags71) explores the complex intersections of race, #HealthEquity & reproductive justice. #lupus #SLE #ReproductiveHealth @ErichHuang Victoria Christian Duke University School of Medicine bit.ly/399cOxE

Such good news - minimal in-school covid transfer in NC school. I really hope Chapel Hill reads this carefully and acts accordingly. My son REALLY needs to get back into the classroom.

High Placebo Responses in SLE Trials A systematic review in randomized controlled trials (RCTs) of non-renal, non-neuropsychiatric systemic lupus erythematosus (SLE) patients showing unexpectedly high placebo responses. Read more: bit.ly/3am3tmC

This doesn't seem surprising to me! How about a new approach to lupus: Type 1 symptoms (inflammation) and Type 2 (chronic pain, fatigue, brain fog). The Type 2 drive people into trials, but the study drugs target pathways for Type 1 disease. pubmed.ncbi.nlm.nih.gov/31909888/

So excited for our newest Duke IM Residency Chiefs. #dukefamily

Congratulations at all, but especially the amazing Nathanial Harris who spent his 3rd yr with me studying pregnancy in women with rheumatic disease. You couldn’t have picked a better chief!

Exciting day for NIAMS! Welcome Dr. Criswell!!! #WomenInScience

Pro-actively assessing pregnancy intention is important to allow for effective pregnancy planning in women with lupus. THIS is how rheumatologists can improve lupus pregnancy outcomes. Duke Health HOP-STEP Lupus Pregnancy physicians.dukehealth.org/articles/new-t…

The visualization of data here looks terrific. If it can get rid of the million-and-one clicks it takes to get through a visit, it would be a tremendous advance.

“Women do not need to choose between their baby and their body. Instead, their rheumatologists, pediatricians, and obstetricians need to be re-assuring that they can safely treat their #arthritis AND #breastfeed at the same time.” -Megan Clowse businesswire.com/news/home/2021…

This week on LSM: Dr. Balevic et al. discover important changes to #hydroxychloroquine #pharmacology during #pregnancy, finding that low drug levels can identify pregnancies at risk for poor outcomes #Lupus Duke Clinical Research Institute Duke Forge Megan Clowse Duke Children's bit.ly/3nbUGuM

This is a great resource for understanding COVID vaccine for immunocompromised people. Thank you Mithu Maheswaranathan, MD - Great work!

Without robust evidence “we really end up with our best-guess treatment,” says Megan Clowse, a rheumatologist at Duke University. “That’s not good enough for our patients.” #lupuspregnancy science.org/content/articl…

So important! Editorial by @dukehealth Megan Clowse Megan Clowse MD MPH and @uofalabama colleague ➡️ Unintended Consequences of SCOTUS Abortion Decision for Patients With Rheumatic Diseases | Annals of Internal Medicine acpjournals.org/doi/10.7326/M2…

#ACR22 Impact of Reproductive Health Legislation on Clinical Rheumatology - You can help pts avoid catastrophic 🤰🏽! - Ask open❓s about 🤰🏽 to promote dialog about reproductive health - Use Discussion Guides & Handouts so she can make decisions that are best for her. American College of Rheumatology

Dr. Christina Chambers, the lead investigator for MotherToBaby Pregnancy Studies, is presenting at #ACR22 on using registry data to inform treatment decisions in pregnancy tomorrow 11/14 at 12pm in room 113. Join us to learn how these studies can help you and your patients!